Physician profile
Alison A Bartfield
NPI 1811974454
$1,292.87
in general payments reported to CMS, 2019-2025
15 companies · $388 in 2025
The $388 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2020: $203 · 2021: $161 · 2022: $82.70 · 2024: $336 · 2025: $388.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $707 · Travel and Lodging: $16.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $707.39 |
| Travel and Lodging | $16.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $272.15 | 2024-2025 | Kisunla |
| Abbvie INC. | $256.56 | 2021-2025 | |
| Allergan, INC. | $231.64 | 2019-2020 | |
| Eisai INC. | $122.55 | 2024 | |
| Rgh Enterprises LLC | $111.08 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $67.72 | 2024 | Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $65.83 | 2022 | |
| Amgen INC. | $28.61 | 2020 | |
| Pfizer INC. | $26.82 | 2019 | |
| Novartis Pharmaceuticals Corporation | $24.84 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $23.10 | 2024 | Rexulti |
| Dexcom, INC. | $17.28 | 2025 | Dexcom G6 Transmitter |
| Janssen Pharmaceuticals, INC | $16.87 | 2022 | |
| Medtronic, INC. | $14.58 | 2021 | |
| Merck Sharp & Dohme LLC | $13.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alison Bartfield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.